生命化学BPOの世界市場分析:サービス別(医薬品外注、医療機器外注、契約セールス、マーケティング外注)、セグメント予測

【英語タイトル】Life Sciences BPO Market Analysis by Services (Pharmaceutical Outsourcing, Medical Devices Outsourcing, Contract Sales, Marketing Outsourcing), and Segment Forecasts to 2024

Grand View Researchが出版した調査資料(GVIEW707483)・商品コード:GVIEW707483
・発行会社(調査会社):Grand View Research
・発行日:2015年7月20日
・ページ数:92
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,700 ⇒換算¥521,700見積依頼/購入/質問フォーム
Multi UserUSD8,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Global/corporate LicenseUSD10,500 ⇒換算¥1,165,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、生命化学BPOの世界市場について調査・分析し、生命化学BPOの世界市場動向、生命化学BPOの世界市場規模、市場予測、セグメント別生命化学BPO市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The life sciences BPO market is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.
The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.

In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth and profitability; altogether these trends are expected to boost the life sciences outsourcing market over the forecast period.

Favorable government initiatives such as the introduction of ICD-10 standards, the increasing adoption of Electronic Health Record systems (EHR), and digital health platforms are enabling the rapid growth of the back-end payer and provider BPO services, such as claims management, claims processing, financial and pay roll management, and other administrative services.

The rising geriatric population coupled with the growing prevalence of various chronic diseases is increasing the burden on the healthcare system and also driving the need for new drugs, and devices, which in turn is expected to boost the contract manufacturing and contract research services over the next nine years.

Moreover, the contract sales and marketing services segments are also expected to witness an increase in demand due to the growing sales and marketing activities for the new product launches over the forecast period.

Further key findings from the study suggest:

In 2015, the pharmaceutical outsourcing segment accounted for the largest revenue share, mainly on account of the growing demand for API and finished dosage form manufacturing services. Moreover, the increasing demand for early stage pre-clinical studies, clinical trials, post-marketing surveillance, and regulatory services are also expected to further drive the market over the forecast period.

The services segment including healthcare payer and provider BPO services is expected to emerge as the fastest growing services type with a CAGR of 9.3% over the forecast period

In the medical devices contract research outsourcing segment, the product design and development category accounted for nearly 29% in 2015. By 2024, the product implementation services are expected to emerge as the fastest growing category with a CAGR of 13.1% from 2016 to 2024.

North America was the largest regional market in 2015. The presence of several major pharmaceuticals, medical device, health insurance, contract research and contract manufacturing (CRAMS) players in this region are amongst the key factors responsible for the region’s large market share. The increasing geriatric population, the growing disease prevalence rates, the shift from ICD 9 to ICD 10 codes are significantly driving the healthcare expenditures and the need for efficient data management, as well as operational costs; therefore, these factors are expected to positively reinforce the life sciences outsourcing market over the forecast period.

Asia Pacific is expected to grow at a CAGR of11% over the forecast period. The increase in the number of U.S. FDA manufacturing sites in this region, especially China and India, the growing healthcare burden, patent expiration of several key drugs are expected to significantly boost the life sciences outsourcing market in this region.

Furthermore, favorable government initiatives to encourage the use of generic drugs, subsidies for the manufacturing of electronic components and devices, and several tax benefits to promote the export of life sciences services from this region are anticipated to further propel the market growth over the forecast period.

Some key market players include Infosys Limited, Lonza Group, PAREXEL International Corporation, Covance, Inc., International Business Machines Corporation. Genpact Limited, Catalent, Inc., ICON plc, Boehringer Ingelheim GmbH, Accenture plc, Quintiles Transnational Corporation, and Anthelio Healthcare Solutions

【レポートの目次】

Table of Contents

Chapter 1 Executive Summary
Chapter 2 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.2 Growing demand for orphan drug discovery
3.1.1.3 Increasing incidences of M&A of CDMO/CRO with big pharma companies
3.1.2 Market Restraint Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Life sciences BPO – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Market Categorization 1: Services Estimates & Trend Analysis
4.1 Life sciences BPO Market: service movement analysis
4.2 Pharmaceutical outsourcing
4.2.1 Pharmaceutical outsourcing market estimates, 2013 – 2015 (USD Billion)
4.2.2 Pharmaceutical outsourcing Market Forecasts, 2016 – 2024 (USD Billion)
4.2.3 Contract Manufacturing
4.2.3.1 Contract manufacturing market estimates, 2013 – 2015 (USD Billion)
4.2.3.2 Contract manufacturing market forecasts, 2016 – 2024 (USD Billion)
4.2.3.3 Active Pharmaceutical Ingredients
4.2.3.3.1 Active pharmaceutical ingredients market estimates, 2013 – 2015 (USD Billion)
4.2.3.3.2 Active pharmaceutical ingredients market forecasts, 2016 – 2024 (USD Billion)
4.2.3.4 Finished Dose Form
4.2.3.4.1 Finished dose form market estimates, 2013 – 2015 (USD Billion)
4.2.3.4.2 Finished dose form market forecasts, 2016 – 2024 (USD Billion)
4.2.3.5 Packaging
4.2.3.5.1 Packagingmarket estimates, 2013 – 2015 (USD Billion)
4.2.3.5.2 Packagingmarket forecasts, 2016 – 2024 (USD Billion)
4.2.4 Contract Research Organizations
4.2.4.1 Contract research organizations market estimates, 2013 – 2015 (USD Billion)
4.2.4.2 Contract research organizations market forecasts, 2016 – 2024 (USD Billion)
4.2.4.3 Drug Discovery
4.2.4.3.1 Drug discovery market estimates, 2013 – 2015 (USD Billion)
4.2.4.3.2 Drug discovery market forecasts, 2016 – 2024 (USD Billion)
4.2.4.4 Preclinical Studies
4.2.4.4.1 Preclinical studies market estimates, 2013 – 2015 (USD Billion)
4.2.4.4.2 Preclinical studies market forecasts, 2016 – 2024 (USD Billion)
4.2.4.5 Clinical Trial Studies
4.2.4.5.1 Clinical trial studies market estimates, 2013 – 2015 (USD Billion)
4.2.4.5.2 Clinical trial studies market forecasts, 2016 – 2024 (USD Billion)
4.2.4.6 Pharmacovigilance
4.2.4.6.1 Pharmacovigilancemarket estimates, 2013 – 2015 (USD Billion)
4.2.4.6.2 Pharmacovigilancemarket forecasts, 2016 – 2024 (USD Billion)
4.2.4.7 Regulatory Services
4.2.4.7.1 Regulatory services market estimates, 2013 – 2015 (USD Billion)
4.2.4.7.2 Regulatory services market forecasts, 2016 – 2024 (USD Billion)
4.3 Medical Devices Outsourcing
4.3.1 Medical devicesoutsourcing market estimates, 2013 – 2015 (USD Billion)
4.3.2 Medical devices outsourcing market forecasts, 2016 – 2024 (USD Billion)
4.3.3 Contract Manufacturing Services
4.3.3.1 Contract manufacturing services market estimates, 2013 – 2015 (USD Billion)
4.3.3.2 Contract manufacturing services market forecasts, 2016 – 2024 (USD Billion)
4.3.3.3 Electronic Manufacturing Services
4.3.3.3.1 Electronic manufacturing services market estimates, 2013 – 2015 (USD Billion)
4.3.3.3.2 Electronic manufacturing services market forecasts, 2016 – 2024 (USD Billion)
4.3.3.4 Finished Goods
4.3.3.4.1 Finished goods market estimates, 2013 – 2015 (USD Billion)
4.3.3.4.2 Finished goods market forecasts, 2016 – 2024 (USD Billion)
4.3.3.5 Raw Materials/Components
4.3.3.5.1 Raw Materials/Components market estimates, 2013 – 2015 (USD Billion)
4.3.3.5.2 Raw Materials/Components market forecasts, 2016 – 2024 (USD Billion)
4.3.4 Regulatory Consulting Services
4.3.4.1 Regulatory consulting services market estimates, 2013 – 2015 (USD Billion)
4.3.4.2 Regulatory consulting services market forecasts, 2016 – 2024 (USD Billion)
4.3.5 Product Design and Development Services
4.3.5.1 Product design and development services market estimates, 2013 – 2015 (USD Billion)
4.3.5.2 Product design and development services market forecasts, 2016 – 2024 (USD Billion)
4.3.6 Product Testing Services
4.3.6.1 Product testing services market estimates, 2013 – 2015 (USD Billion)
4.3.6.2 Product testing services market forecasts, 2016 – 2024 (USD Billion)
4.3.7 Product Implementation Services
4.3.7.1 Product implementation services market estimates, 2013 – 2015 (USD Billion)
4.3.7.2 Product implementation services market forecasts, 2016 – 2024 (USD Billion)
4.3.8 Product Upgrade Services
4.3.8.1 Product upgrade services market estimates, 2013 – 2015 (USD Billion)
4.3.8.2 Product upgrade services market forecasts, 2016 – 2024 (USD Billion)
4.3.9 Product Maintenance Services
4.3.9.1 Product maintenance services market estimates, 2013 – 2015 (USD Billion)
4.3.9.2 Product maintenance services market forecasts, 2016 – 2024 (USD Billion)
4.4 Contract Sales and Marketing Organization
4.4.1 Contract sales and marketing organizationmarket estimates, 2013 – 2015 (USD Billion)
4.4.2 Contract sales and marketing organizationmarket forecasts, 2016 – 2024 (USD Billion)
4.5 Others (Payers and Providers)
4.5.1 Others (payers and providers) market estimates, 2013 – 2015 (USD Billion)
4.5.2 Others (payers and providers) market forecasts, 2016 – 2024 (USD Billion)
Chapter 5 Market Categorization 3: Regional Estimates & Trend Analysis, by Product & Application
5.1 Life sciences BPO Market share by region, 2013 & 2020
5.2 North America
5.2.1 North America life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.2.2 North America life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.2.3 U.S.
5.2.4 U.S. life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.2.5 U.S. life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.2.6 Canada
5.2.7 Canada life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.2.8 Canada life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.3 Europe
5.3.1 Europe life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.3.2 Europe life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.3.3 Germany
5.3.4 Germany life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.3.5 Germany life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.3.6 UK
5.3.7 UK life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.3.8 UK life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.4 Asia-Pacific
5.4.1 Asia-Pacific life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.4.2 Asia-Pacific life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.4.3 Japan
5.4.4 Japan life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.4.5 Japan life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.4.6 China
5.4.7 China life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.4.8 China life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.4.9 India
5.4.10 India life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.4.11 India life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.5 Latin America
5.5.1 Latin America life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.5.2 Latin America life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.5.3 Brazil
5.5.4 Brazil life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.5.5 Brazil life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.5.6 Mexico
5.5.7 Mexico life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.5.8 Mexico life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.6 MEA
5.6.1 MEA life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.6.2 MEA life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
5.6.3 South Africa
5.6.4 South Africa life sciences BPO market estimates, by services 2013 – 2015 (USD Billion)
5.6.5 South Africa life sciences BPO market forecasts, by services 2016 – 2024 (USD Billion)
Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Anthelio Healthcare Solutions
6.3.1.1 Company Overview
6.3.1.2 Financial Performance
6.3.1.3 Product Benchmarking
6.3.1.4 Strategic Initiatives
6.3.2 Boehringer Ingelheim GmbH
6.3.2.1 Company Overview
6.3.2.2 Financial Performance
6.3.2.3 Product Benchmarking
6.3.2.4 Strategic Initiatives
6.3.3 Catalent, Inc.
6.3.3.1 Company Overview
6.3.3.2 Financial Performance
6.3.3.3 Product Benchmarking
6.3.3.4 Strategic Initiatives
6.3.4 Covance, Inc.
6.3.4.1 Company Overview
6.3.4.2 Financial Performance
6.3.4.3 Product Benchmarking
6.3.4.4 Strategic Initiatives
6.3.5 Genpact Limited
6.3.5.1 Company Overview
6.3.5.2 Financial Performance
6.3.5.3 Product Benchmarking
6.3.5.4 Strategic Initiatives
6.3.6 ICON plc
6.3.6.1 Company Overview
6.3.6.2 Financial Performance
6.3.6.3 Product Benchmarking
6.3.6.4 Strategic Initiatives
6.3.7 Infosys Limited
6.3.7.1 Company Overview
6.3.7.2 Financial Performance
6.3.7.3 Product Benchmarking
6.3.7.4 Strategic Initiatives
6.3.8 International Business Machines Corporation
6.3.8.1 Company Overview
6.3.8.2 Financial Performance
6.3.8.3 Product Benchmarking
6.3.8.4 Strategic Initiatives
6.3.9 Lonza Group
6.3.9.1 Company Overview
6.3.9.2 Financial Performance
6.3.9.3 Product Benchmarking
6.3.9.4 Strategic Initiatives
6.3.10 PAREXEL International Corporation
6.3.10.1 Company Overview
6.3.10.2 Financial Performance
6.3.10.3 Product Benchmarking
6.3.10.4 Strategic Initiatives
6.3.11 Quintiles Transnational Corporation
6.3.11.1 Company Overview
6.3.11.2 Financial Performance
6.3.11.3 Product Benchmarking
6.3.11.4 Strategic Initiatives
6.3.12 Accenture plc
6.3.12.1 Company Overview
6.3.12.2 Financial Performance
6.3.12.3 Product Benchmarking
6.3.12.4 Strategic Initiatives
6.3.13 Wipro Limited
6.3.13.1 Company Overview
6.3.13.2 Financial Performance
6.3.13.3 Product Benchmarking
6.3.13.4 Strategic Initiatives
6.3.14 Cognizant Technology Solutions
6.3.14.1 Company Overview
6.3.14.2 Financial Performance
6.3.14.3 Product Benchmarking
6.3.14.4 Strategic Initiatives

List of Figures

FIG. 1 Market Summary
FIG. 2 Market Trends & Outlook
FIG. 3 Market Segmentation & Scope
FIG. 4 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 5 Count of Acquire Company By Deal Value, 2015
FIG. 6 Market Restraint Relevance Analysis (Current &Future Impact)
FIG. 7 Penetration & Growth Prospect Mapping
FIG. 8 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
FIG. 9 Porter’s Five Forces Analysis
FIG. 10 Life Sciences BPO market service outlook key takeaways
FIG. 11 Life Sciences BPO market: services movement analysis
FIG. 12 Global pharmaceutical outsourcing market estimates, 2013 - 2015 (USD Billion)
FIG. 13 Global pharmaceutical outsourcing market forecasts, 2016 - 2024 (USD Billion)
FIG. 14 Global contract manufacturing market estimates, 2013 - 2015 (USD Billion)
FIG. 15 Global contract manufacturing market forecasts, 2016 - 2024 (USD Billion)
FIG. 16 Global active pharmaceutical ingredients market estimates, 2013 - 2015 (USD Billion)
FIG. 17 Global active pharmaceutical ingredients market forecasts, 2016 - 2024 (USD Billion)
FIG. 18 Global finished dose form market estimates, 2013 - 2015 (USD Billion)
FIG. 19 Global finished dose form market forecasts, 2016 - 2024 (USD Billion)
FIG. 20 Global packaging market estimates, 2013 - 2015 (USD Billion)
FIG. 21 Global packaging market forecasts, 2016 - 2024 (USD Billion)
FIG. 22 Global contract research organizations market estimates, 2013 - 2015 (USD Billion)
FIG. 23 Global contract research organizations market forecasts, 2016 - 2024 (USD Billion)
FIG. 24 Global drug discovery market estimates, 2013 - 2015 (USD Billion)
FIG. 25 Global drug discovery market forecasts, 2016 - 2024 (USD Billion)
FIG. 26 Global preclinical studies market estimates, 2013 - 2015 (USD Billion)
FIG. 27 Global preclinical studies market forecasts, 2016 - 2024 (USD Billion)
FIG. 28 Global clinical trial studies market estimates, 2013 - 2015 (USD Billion)
FIG. 29 Global clinical trial studies market forecasts, 2016 - 2024 (USD Billion)
FIG. 30 Global pharmacovigilance market estimates, 2013 - 2015 (USD Billion)
FIG. 31 Global pharmacovigilance market forecasts, 2016 - 2024 (USD Billion)
FIG. 32 Global regulatory services market estimates, 2013 - 2015 (USD Billion)
FIG. 33 Global regulatory services market forecasts, 2016 - 2024 (USD Billion)
FIG. 34 Global medical devices outsourcing market estimates, 2013 - 2015 (USD Billion)
FIG. 35 Global medical devices outsourcing market forecasts, 2016 - 2024 (USD Billion)
FIG. 36 Global contract manufacturing services market estimates, 2013 - 2015 (USD Billion)
FIG. 37 Global contract manufacturing services market forecasts, 2016 - 2024 (USD Billion)
FIG. 38 Global electronic manufacturing services market estimates, 2013 - 2015 (USD Billion)
FIG. 39 Global electronic manufacturing services market forecasts, 2016 - 2024 (USD Billion)
FIG. 40 Global finished goods market estimates, 2013 - 2015 (USD Billion)
FIG. 41 Global finished goods market forecasts, 2016 - 2024 (USD Billion)
FIG. 42 Global raw materials/components market estimates, 2013 - 2015 (USD Billion)
FIG. 43 Global raw materials/components market forecasts, 2016 - 2024 (USD Billion)
FIG. 44 Global regulatory consulting services market estimates, 2013 - 2015 (USD Billion)
FIG. 45 Global regulatory consulting services market forecasts, 2016 - 2024 (USD Billion)
FIG. 46 Global product design and development services market estimates, 2013 - 2015 (USD Billion)
FIG. 47 Global product design and development services market forecasts, 2016 - 2024 (USD Billion)
FIG. 48 Global product testing services market estimates, 2013 - 2015 (USD Billion)
FIG. 49 Global product testing services market forecasts, 2016 - 2024 (USD Billion)
FIG. 50 Global product implementation services market estimates, 2013 - 2015 (USD Billion)
FIG. 51 Global product implementation services market forecasts, 2016 - 2024 (USD Billion)
FIG. 52 Global product upgrade services market estimates, 2013 - 2015 (USD Billion)
FIG. 53 Global product upgrade services market forecasts, 2016 - 2024 (USD Billion)
FIG. 54 Global product maintenance services market estimates, 2013 - 2015 (USD Billion)
FIG. 55 Global product maintenance services market forecasts, 2016 - 2024 (USD Billion)
FIG. 56 Global contract sales and marketing organization market estimates, 2013 - 2015 (USD Billion)
FIG. 57 Global contract sales and marketing organization market forecasts, 2016 - 2024 (USD Billion)
FIG. 58 Global others( payers and providers) market estimates, 2013 - 2015 (USD Billion)
FIG. 59 Global others( payers and providers) market forecasts, 2016 - 2024 (USD Billion)
FIG. 60 Regional Market Place: Key Takeaways
FIG. 61 Regional Outlook, 2015 & 2022
FIG. 62 North America Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 63 North America Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 64 U.S. Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG.65 U.S. Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 66 Canada Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 67 Canada Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 68 Europe Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 69 Europe Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 70 Germany Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 71 Germany Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 72 UK Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 73 UK Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 74 Asia-Pacific Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 75 Asia-Pacific Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 76 Japan Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 77 Japan Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 78 China Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 79 China Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 80 India Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 81 India Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 82 Latin America Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 83 Latin America Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 84 Brazil Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 85 Brazil Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 86 Mexico Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 87 Mexico Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG.88 MEA Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 89 MEA Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 90 South Africa Life Sciences BPO market estimates, by services 2013 - 2015 (USD Billion)
FIG. 91 South Africa Life Sciences BPO market forecasts, by services 2016 - 2024 (USD Billion)
FIG. 92 Strategy Framework
FIG. 93 Participant Categorization



★調査レポート[生命化学BPOの世界市場分析:サービス別(医薬品外注、医療機器外注、契約セールス、マーケティング外注)、セグメント予測] (コード:GVIEW707483)販売に関する免責事項を必ずご確認ください。
★調査レポート[生命化学BPOの世界市場分析:サービス別(医薬品外注、医療機器外注、契約セールス、マーケティング外注)、セグメント予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆